← THERMO FISHER SCIENTIFIC INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Accounts receivable, less allowances of $147 and $173 $3.0b $3.9b $4.1b $4.3b $5.7b $8.0b $8.1b $8.2b $8.2b $8.9b
Cash and Cash Equivalents, at Carrying Value $786.2m $1.3b $2.1b $2.4b $10.3b $4.5b $8.5b $8.1b $4.0b $9.9b
Cash and cash equivalents $786.2m $1.3b $2.1b $2.4b $10.3b $4.5b $8.5b $8.1b $4.0b $9.9b
Other current assets $594.7m $804.0m $1.4b $1.2b $1.1b $1.6b $1.6b $1.8b $2.0b $2.6b
Short-term Investments — — — — — — — $3.0m $1.6b $253.0m
Inventory, Net $2.2b $3.0b $3.0b $3.4b $4.0b $5.1b $5.6b $5.1b $5.0b $5.4b
Assets, Current $7.0b $9.4b $10.6b $11.9b $22.0b $20.1b $25.2b $24.6b $22.1b $28.7b
Total current assets $7.0b $9.4b $10.6b $11.9b $22.0b $20.1b $25.2b $24.6b $22.1b $28.7b
Property, Plant and Equipment, Net $2.6b $4.0b $4.2b $4.7b $5.9b $8.3b $9.3b $9.4b $9.3b $10.6b
Acquisition-related intangible assets, net $14.0b $16.7b $15.0b $14.0b $12.7b $20.1b $17.4b $16.7b $15.5b $15.8b
Goodwill $21.3b $25.3b $25.3b $25.7b $26.0b $41.9b $41.2b $44.0b $45.9b $49.4b
Intangible Assets, Net (Excluding Goodwill) $14.0b $16.7b $15.0b $14.0b $12.7b $20.1b $17.4b $16.7b $15.5b $15.8b
Operating Lease, Right-of-Use Asset — — — $699.0m $775.0m $1.5b $1.6b $1.6b $1.5b $1.4b
Other Assets, Noncurrent $1.0b $1.2b $1.1b $2.0b $2.5b $4.6b $4.0b $4.0b $4.5b $5.9b
Other assets $1.0b $1.2b $1.1b $2.0b $2.5b $4.6b $4.0b $4.0b $4.5b $5.9b
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $3.0b $3.9b $4.1b $4.3b $5.7b $8.0b $8.1b $8.2b $8.2b $8.9b
Capital in excess of par value $12.1b $14.2b $14.6b $15.1b $15.6b $16.2b $16.7b $17.3b $18.0b $18.6b
Contract assets, net — — $459.0m $603.0m $731.0m $968.0m $1.3b $1.4b $1.4b $1.7b
Contract liabilities — $0 $809.0m $916.0m $1.3b $2.7b $2.6b $2.7b $2.9b $2.7b
Deferred income taxes $2.6b $2.8b $2.3b $2.2b $1.8b $3.8b $2.8b $1.9b $1.3b $1.5b
Long-term obligations $15.4b $18.9b $17.7b $17.1b $19.1b $32.3b $28.9b $31.3b $29.1b $35.9b
Short-term obligations and current maturities of long-term obligations $1.3b $2.1b $1.3b $676.0m $2.6b $2.5b $5.6b $3.6b $2.2b $3.5b
Total Thermo Fisher Scientific Inc. shareholders’ equity $21.5b $25.4b $27.6b $29.7b $34.5b $40.8b $44.0b $46.7b $49.6b $53.4b
Total equity — — — — $34.5b $40.9b $44.0b $46.7b $49.6b $53.4b
Assets $45.9b $56.7b $56.2b $58.4b $69.1b $95.1b $97.2b $98.7b $97.3b $110.3b
Total assets $45.9b $56.7b $56.2b $58.4b $69.1b $95.1b $97.2b $98.7b $97.3b $110.3b
LIABILITIES AND EQUITY
Current liabilities:
Accounts Payable, Current $926.2m $1.4b $1.6b $1.9b $2.2b $2.9b $3.4b $2.9b $3.1b $3.6b
Accrued payroll and employee benefits $708.7m $918.0m $982.0m $1.0b $1.9b $2.4b $2.1b $1.6b $2.0b $2.0b
Deferred Revenue, Current $485.9m $719.0m $0 — — — — — — —
Dividends Payable $60.1m $61.0m $69.0m $77.0m $89.0m $104.0m $119.0m $137.0m $150.0m $164.0m
Long-term Debt, Excluding Current Maturities $1.3b $2.1b $1.3b $17.1b $19.1b $34.7b $34.3b $34.7b $31.1b $39.2b
Operating Lease, Liability, Current — — — $167.0m $184.0m $266.0m $272.0m $263.0m $261.0m $275.0m
Operating Lease, Liability, Noncurrent — — — $571.0m $626.0m $1.2b $1.3b $1.2b $1.2b $1.2b
Other accrued expenses $1.3b $1.8b $1.5b $1.7b $2.3b $3.0b $3.4b $3.2b $3.2b $3.3b
Liabilities, Current $4.9b $7.0b $6.1b $6.2b $10.3b $13.4b $17.0b $14.0b $13.3b $15.2b
Total current liabilities $4.9b $7.0b $6.1b $6.2b $10.3b $13.4b $17.0b $14.0b $13.3b $15.2b
Deferred Income Tax Liabilities, Net $2.6b $2.8b $2.3b $2.2b $1.8b $3.8b $2.8b $1.9b $1.3b $1.5b
Long-term Debt — — — $17.1b $19.1b $34.7b $34.3b $34.7b $31.1b $39.2b
Other Liabilities, Noncurrent $1.6b $2.6b $2.5b $3.2b $3.3b $4.5b $4.2b $4.6b $4.0b $4.3b
Other long-term liabilities $1.6b $2.6b $2.5b $3.2b $3.3b $4.5b $4.2b $4.6b $4.0b $4.3b
Deferred Tax Liabilities, Net $2.2b $2.3b $1.8b $1.6b $1.1b $2.8b $2.0b $1.1b $338.0m —
Redeemable Noncontrolling Interest, Equity, Carrying Amount — — — — — $122.0m $116.0m $118.0m $120.0m $122.0m
Redeemable noncontrolling interest — — — — $0 $122.0m $116.0m $118.0m $120.0m $122.0m
Stockholders’ equity:
Accumulated Other Comprehensive Income (Loss), Net of Tax ($2.6b) ($2.0b) ($2.5b) ($2.7b) ($2.8b) ($2.3b) ($3.1b) ($3.2b) ($2.7b) ($2.4b)
Accumulated other comprehensive income/(loss) ($2.6b) ($2.0b) ($2.5b) ($2.7b) ($2.8b) ($2.3b) ($3.1b) ($3.2b) ($2.7b) ($2.4b)
Additional Paid in Capital, Common Stock $12.1b $14.2b $14.6b $15.1b $15.6b $16.2b $16.7b $17.3b $18.0b $18.6b
Common Stock, Value, Issued $415.1m $428.0m $432.0m $434.0m $437.0m $439.0m $441.0m $442.0m $444.0m $445.0m
Common stock, $1 par value, 1,200,000,000 shares authorized; 445,160,301 and 443,841,240 shares issued $415.1m $428.0m $432.0m $434.0m $437.0m $439.0m $441.0m $442.0m $444.0m $445.0m
Preferred Stock, Value, Issued — — — — — — — — $0 $0
Preferred stock, $100 par value, 50,000 shares authorized; none issued — — — — — — — — $0 $0
Retained Earnings (Accumulated Deficit) $13.9b $15.9b $18.7b $22.1b $28.1b $35.4b $41.9b $47.4b $53.1b $59.2b
Treasury stock at cost, 68,938,831 and 63,066,906 shares — ($3.1b) ($3.7b) ($5.2b) ($6.8b) ($8.9b) ($12.0b) ($15.1b) ($19.2b) ($22.3b)
Stockholders' Equity Attributable to Parent $21.5b $25.4b $27.6b $29.7b $34.5b $40.8b $44.0b $46.7b $49.6b $53.4b
Noncontrolling interests — — — — $10.0m $62.0m $54.0m ($11.0m) ($33.0m) $7.0m
Stockholders' Equity Attributable to Noncontrolling Interest — — — — — $62.0m $54.0m ($11.0m) ($33.0m) $7.0m
Liabilities and Equity $45.9b $56.7b $56.2b $58.4b $69.1b $95.1b $97.2b $98.7b $97.3b $110.3b
Total liabilities, redeemable noncontrolling interest and equity $45.9b $56.7b $56.2b $58.4b $69.1b $95.1b $97.2b $98.7b $97.3b $110.3b

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.